Inovio Pharma (INO) Announces Filing of MERS Vaccine IND with U.S. FDA
Tweet Send to a Friend
GeneOne Life Science Inc., which partnered with Inovio Pharmaceuticals, Inc. (Nasdaq: INO) to develop Inovio’s MERS vaccine (GLS-5300), announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE